Recap: Vistagen Therapeutics Q3 Earnings

Vistagen Therapeutics VTGN reported its Q3 earnings results on Tuesday, February 13, 2024 at 04:21 PM.

Here's what investors need to know about the announcement.

Earnings

Vistagen Therapeutics beat estimated earnings by 26.67%, reporting an EPS of $-0.22 versus an estimate of $-0.3.

Revenue was up $231 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.02 which was followed by a 11.07% drop in the share price the next day.

To track all earnings releases for Vistagen Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.